Trials / Unknown
UnknownNCT02665832
Study of DWJ1351 in Healthy Male Volunteers
A Randomized, Open-label, Single-Dose, 2-Way Cross-over Study To Compare the Safety and Pharmacokinetic Characteristics of Combination of Amlodipine, Olmesartan and Rosuvastatin and DWJ1351 in Healthy Male Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the safety and pharmacokinetic characteristics of combination of amlodipine, olmesartan and rosuvastatin and DWJ1351 in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1351 | |
| DRUG | Co-administration of Sevikar (Olmesartan/Amlodipine) and Crestor (Rosuvastatin) |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-01-28
- Last updated
- 2016-01-28
Source: ClinicalTrials.gov record NCT02665832. Inclusion in this directory is not an endorsement.